Recent Analysts’ Ratings Changes for Colgate-Palmolive (CL)

Several brokerages have updated their recommendations and price targets on shares of Colgate-Palmolive (NYSE: CL) in the last few weeks:

• 4/29/2025 – Colgate-Palmolive was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 4/28/2025 – Colgate-Palmolive had its price target raised by analysts at JPMorgan Chase & Co. from $95.00 to $103.00. They now have an “overweight” rating on the stock.
• 4/28/2025 – Colgate-Palmolive had its price target raised by analysts at Citigroup Inc. from $103.00 to $108.00. They now have a “buy” rating on the stock.
• 4/17/2025 – Colgate-Palmolive had its price target raised by analysts at UBS Group AG from $105.00 to $109.00. They now have a “buy” rating on the stock.
• 4/16/2025 – Colgate-Palmolive was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 4/11/2025 – Colgate-Palmolive had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $95.00. They now have an “overweight” rating on the stock.
• 4/11/2025 – Colgate-Palmolive had its price target lowered by analysts at Barclays PLC from $89.00 to $86.00. They now have an “equal weight” rating on the stock.
• 4/4/2025 – Colgate-Palmolive was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 4/2/2025 – Colgate-Palmolive had its price target raised by analysts at Wells Fargo & Company from $83.00 to $88.00. They now have an “underweight” rating on the stock.
• 3/31/2025 – Colgate-Palmolive had its price target lowered by analysts at Piper Sandler from $108.00 to $107.00. They now have an “overweight” rating on the stock.
• 3/27/2025 – Colgate-Palmolive had its price target raised by analysts at Barclays PLC from $83.00 to $89.00. They now have an “equal weight” rating on the stock.
• 3/25/2025 – Colgate-Palmolive was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 3/14/2025 – Colgate-Palmolive had its price target raised by analysts at JPMorgan Chase & Co. from $97.00 to $99.00. They now have an “overweight” rating on the stock.
• 3/14/2025 – Colgate-Palmolive was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.

Colgate-Palmolive Price Performance

CL traded up $0.60 during midday trading on Tuesday, hitting $91.34. The company had a trading volume of 628,360 shares, compared to its average volume of 4,623,714. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The firm’s 50-day simple moving average is $92.27 and its 200-day simple moving average is $91.72. The company has a market capitalization of $74.02 billion, a PE ratio of 25.95, a P/E/G ratio of 4.20 and a beta of 0.39. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same period last year, the firm earned $0.86 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.28%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive’s payout ratio is 58.76%.

Hedge Funds Weigh In On Colgate-Palmolive

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank bought a new position in Colgate-Palmolive during the fourth quarter worth about $912,375,000. Diamond Hill Capital Management Inc. bought a new stake in Colgate-Palmolive during the 4th quarter worth about $348,718,000. AMF Tjanstepension AB boosted its position in Colgate-Palmolive by 1,088.8% during the fourth quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after purchasing an additional 2,353,268 shares during the last quarter. Barclays PLC boosted its holdings in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Finally, Deutsche Bank AG grew its stake in shares of Colgate-Palmolive by 35.6% in the fourth quarter. Deutsche Bank AG now owns 6,922,994 shares of the company’s stock valued at $629,369,000 after buying an additional 1,816,865 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.